Funding for this research was provided by:
norges forskningsråd (228415)
dentsply implants (I-AS-14-009)
Received: 29 June 2021
Accepted: 15 November 2021
First Online: 25 November 2021
: The Regional Ethics Committee for Animal Research of the University of Santiago de Compostela approved the protocol (Ref. AE-LU-001/002/14).
: Not applicable.
: Haugen, Ellingsen, Tiainen and Lyngstadaas are inventors of the technology behind the production of TiO<sub>2</sub> scaffold (WO2014044672, WO2008078164). The commercial rights for the TiO<sub>2</sub> scaffold belongs to Corticalis AS. Haugen, Ellingsen, Lyngstadaas, Rønold and Wohlfahrt are shareholder of Corticalis AS.